Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christos D Katsetos

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Seminars in Pediatric Neurology|May 16, 2015
Emerging Molecularly-Targeted Therapeutic Strategies in Brain Cancer. IntroductionChristos D Katsetos
Journal of Child Neurology|January 14, 2012
Patterns of cognitive and fine motor deficits in a case of Dandy-Walker continuumAlexandra Economou, Christos D Katsetos
Seminars in Pediatric Neurology|December 17, 2014
Experimental studies in epilepsy: immunologic and inflammatory mechanismsAgustín Legido, Christos D Katsetos
Current Pharmaceutical Design|March 7, 2012
Tubulins as therapeutic targets in cancer: from bench to bedsideChristos D Katsetos, Pavel Dráber
Seminars in Pediatric Neurology|December 17, 2013
Mitochondrial dysfunction in gliomasChristos D Katsetos, Helen Anni, Pavel Dráber
Anti-Cancer Agents in Medicinal Chemistry|June 29, 2011
Targeting βIII-tubulin in glioblastoma multiforme: from cell biology and histopathology to cancer therapeuticsChristos D Katsetos, Pavel Draber, Maria Kavallaris
The Journal of Neuropsychiatry and Clinical Neurosciences|September 13, 2013
Psychiatric disturbance and mild intellectual disability in the context of a vascular malformation (capillary telangiectasia) of the posterior hippocampus and subiculumAlexandra Economou, Gloria X Zhang, Christos D Katsetos
Seminars in Pediatric Neurology|December 17, 2013
Mitochondrial dysfunction in neuromuscular disordersChristos D Katsetos, Sirma Koutzaki, Joseph J Melvin
Cell Motility and the Cytoskeleton|May 13, 2003
Class III beta-tubulin in human development and cancerChristos D Katsetos, Mary M Herman, Sverre J Mörk
Journal of Cellular Physiology|August 4, 2009
Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. II. gamma-TubulinChristos D Katsetos, Eduarda Dráberová, Agustin Legido, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Seminars in Pediatric Neurology|May 16, 2015
Emerging Molecularly-Targeted Therapeutic Strategies in Brain Cancer. IntroductionChristos D Katsetos
Journal of Child Neurology|January 14, 2012
Patterns of cognitive and fine motor deficits in a case of Dandy-Walker continuumAlexandra Economou, Christos D Katsetos
Seminars in Pediatric Neurology|December 17, 2014
Experimental studies in epilepsy: immunologic and inflammatory mechanismsAgustín Legido, Christos D Katsetos
Current Pharmaceutical Design|March 7, 2012
Tubulins as therapeutic targets in cancer: from bench to bedsideChristos D Katsetos, Pavel Dráber
Seminars in Pediatric Neurology|December 17, 2013
Mitochondrial dysfunction in gliomasChristos D Katsetos, Helen Anni, Pavel Dráber
Anti-Cancer Agents in Medicinal Chemistry|June 29, 2011
Targeting βIII-tubulin in glioblastoma multiforme: from cell biology and histopathology to cancer therapeuticsChristos D Katsetos, Pavel Draber, Maria Kavallaris
The Journal of Neuropsychiatry and Clinical Neurosciences|September 13, 2013
Psychiatric disturbance and mild intellectual disability in the context of a vascular malformation (capillary telangiectasia) of the posterior hippocampus and subiculumAlexandra Economou, Gloria X Zhang, Christos D Katsetos
Seminars in Pediatric Neurology|December 17, 2013
Mitochondrial dysfunction in neuromuscular disordersChristos D Katsetos, Sirma Koutzaki, Joseph J Melvin
Cell Motility and the Cytoskeleton|May 13, 2003
Class III beta-tubulin in human development and cancerChristos D Katsetos, Mary M Herman, Sverre J Mörk
Journal of Cellular Physiology|August 4, 2009
Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. II. gamma-TubulinChristos D Katsetos, Eduarda Dráberová, Agustin Legido, et al.
Pageof 6